It’s a very interesting study and a compelling idea. I think the big issue is that we need to look at the marginal impact of extra dollars on cancer research, this is looking at the average impact of money spent on cancer drug trials. Expected effectiveness of more money should be lower, as the most promising drugs are more likely to already have funding.
It’s a very interesting study and a compelling idea. I think the big issue is that we need to look at the marginal impact of extra dollars on cancer research, this is looking at the average impact of money spent on cancer drug trials. Expected effectiveness of more money should be lower, as the most promising drugs are more likely to already have funding.